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Abstract
Background: Long terminal repeats (LTR) from endogenous retroviruses (ERV) are source of binding sites for
transcription factors which affect the host regulatory networks in different cell types, including pluripotent cells.
The embryonic epiblast is made of pluripotent cells that are subjected to opposite transcriptional regulatory
networks to give rise to distinct embryonic and extraembryonic lineages. To assess the transcriptional contribution
of ERV to early developmental processes, we have characterized in vitro and in vivo the regulation of ENS-1, a host
adopted and developmentally regulated ERV that is expressed in chick embryonic stem cells.
Results: We show that Ens-1 LTR activity is controlled by two transcriptional pathways that drive pluripotent cells
to alternative developmental fates. Indeed, both Nanog that maintains pluripotency and Gata4 that induces
differentiation toward extraembryonic endoderm independently activate the LTR. Ets coactivators are required to
support Gata factors’ activity thus preventing inappropriate activation before epigenetic silencing occurs during
differentiation. Consistent with their expression patterns during chick embryonic development, Gata4, Nanog and
Ets1 are recruited on the LTR in embryonic stem cells; in the epiblast the complementary expression of Nanog and
Gata/Ets correlates with the Ens-1 gene expression pattern; and Ens-1 transcripts are also detected in the hypoblast,
an extraembryonic tissue expressing Gata4 and Ets2, but not Nanog. Accordingly, over expression of Gata4 in
embryos induces an ectopic expression of Ens-1.
Conclusion: Our results show that Ens-1 LTR have co-opted conditions required for the emergence of
extraembryonic tissues from pluripotent epiblasts cells. By providing pluripotent cells with intact binding sites for
Gata, Nanog, or both, Ens-1 LTR may promote distinct transcriptional networks in embryonic stem cells
subpopulations and prime the separation between embryonic and extraembryonic fates.
Background
Long terminal repeats (LTR) from endogenous retro-
viruses (ERV) are remnants of transposable elements
disseminated in the genome that contain promoter
activity [1] and can control nearby genes in different
organisms [2-5]. They represent a source of binding
sites for transcription factors [6], and some that are
active in embryonic stem (ES) cells have been shown to
rewire the Nanog and Oct3/4 transcriptional networks
in a species-specific manner [7]. Whether these changes
are neutral or reflect species-specific adaptation to con-
served developmental processes is not known, but ERV
that escape silencing in pluripotent cells have been
described in several species [4,8].
ES cells are isolated from the inner cell mass of very
early embryos and can generate all the cells of an organ-
ism [9], a unique property called pluripotency that is
supported by Oct3/4 [10], Sox2 [11] and Nanog [12]
transcription factors. Oct3/4 and Nanog inhibit
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lineages, the latter providing nutrient exchange and
inductive signals for the embryo [13]. These functions
are well conserved in ES cells from different species,
including chicken [14]. In vivo, the emergence of extra-
embryonic tissues from pluripotent cells represents the
first cell fate decision and precedes the differentiation of
the embryonic lineages. Notably in different species,
Nanog deficiency makes the cells tolerant to differentia-
tion into extraembryonic endoderm lineages [15-17]
allowing the action of Gata-6 [18] and Gata-4 [19,20]
transcription factors to drive extraembryonic endoderm
formation. However, it is not clear what mechanisms
guide pluripotent cells toward embryonic or extraem-
bryonic lineages upon the suppression of the controls
exerted by Oct3/4 [21] and Nanog [15].
To better understand the contribution of LTR to the
transcriptional networks available in ES cells, we focused
our interest on a developmentally regulated ERV and
characterized its transcriptional regulation. The Ens-1
LTR controls the expression of a multigenic family of
genes of retroviral origin, ENS (Embryonic Normal Stem
cell), present only in Galliform species. The Ens-1 copy
presents the most complete coding region and has been
maintained in Galliform genomes through negative
selection pressure [22] as observed for host-adopted ret-
rotransposons [23]. Ens-1 also called Erni,i se x p r e s s e d
in pluripotent cells of the epiblast and later in the pro-
spective neural plate [24,25], where it has been demon-
strated to delay the expression of Sox2 [26] affecting the
timing of emergence of the definitive neural plate and
thus embryonic patterning. In vitro, Ens-1 is expressed
in chicken ES (cES) cells [25] and is repressed when ES
cells differentiation is induced, mimicking the repression
of the Ens-1 LTR as further development occurs [27]. In
addition to the coding regions, more than 800 copies of
solo-LTR are disseminated and placed in close contact
to host genes in sense or in anti-sense orientations [22]
where they might act as alternative promoters [28]. We
show here that the Ens-1 LTR is under the control of
both Nanog and Gata factors in such a way that may
direct the formation of the extraembryonic endoderm
when ES cells exit pluripotency.
Results
A cooperation between distinct DNA motifs controls the
activity of the Ens-1 promoter
The promoter activity of Ens-1 in the chicken ES (cES)
cells is supported by a 455 bp sequence (p455) upstream
of the transcription initiation site and isolated from the
U3 domain of the whole LTR [25]. The transcription
factor CP2 that partially controls p455 activity binds to
a domain located within the already explored 277 bp of
the 5’ end of this region [27]. Deletions within the first
237 bp of p455 placed upstream of a firefly luciferase
reporter gene have allowed us to find major determi-
nants for the promoter activity between the positions
-179 and -128 (Additional file 1: Figure S1). To reveal
active binding sites for transcription factors, a series of
site-directed deletions were performed in this region
(Figure 1A). Four sites, S1 to S4, contributed to Ens-1
promoter activity, and single deletions of each of them
were not sufficient to abrogate the promoter activity to
the same extent as the whole -179/-128 deletion (90%
inhibition) (Figure 1B). No inhibition was obtained after
site directed deletions downstream of position -128,
including those in two putative [27] Gata binding sites
(Additional file 1: Figure S1). These results suggest that
several elements cooperate for the full promoter activity,
as confirmed by the analysis of combined mutations of
these four sites which inhibited the activity of the p455
construct with the same efficiency as a large deletion.
Site S2 was separated from site S3 by only three nucleo-
tides suggesting a close contact between factors occupy-
ing both sites and a narrow sequence specificity of the
inhibiting deletions when compared with other close
mutations.
It thus seems that the Ens-1 promoter is controlled by
a combination of DNA binding proteins recognizing dis-
tinct and specific motifs and acting in a synergistic man-
ner to promote the transcriptional activity.
The active domains are differently involved in the
recruitment of ES specific protein complexes on the
promoter
To address the role of the DNA active motifs in the
recruitment of protein complexes, electrophoretic mobi-
lity shift assays (EMSA) were performed with nuclear
extracts from cES cells. A
32P end-labelled double
stranded oligonucleotide, spanning sites S1 to S3 and
called p40, was used as a probe and was compared with
the same sequence carrying mutations on sites S1, S2 or
S3 (Figure 1A). To compare probes of similar sizes, the
mutations were made by substitution. The p40 probe
formed three different protein-DNA complexes, x, y and
z (Figure 1C), the latest being sometimes resumed to a
single band as illustrated in Figure 1D. These complexes
were competed off by a 100-fold molar excess of unla-
belled probe, but only the complex x resisted to a 100-
fold molar excess of an irrelevant unlabelled probe indi-
cating specific binding only for x (Figure 1C). When
using nuclear extracts from cES cells induced to differ-
entiate for four days with retinoic acid, no complex was
formed on the DNA probe (Figure 1D) indicating that
the binding was specific for pluripotent stem cells. As
shown in Figure 1C the mutation of the S1 site did not
affect complex formation, while mutation of the S3 site
inhibited the formation of the complex x. The double
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obtained with the single S3 mutant version, confirming
that S1 was not involved in complex formation. The
mutation S2 (Figure 1D) completely inhibited the forma-
tion of the complex.
Altogether, these results indicate that a protein com-
plex is specific for undifferentiated cES cells bound to
the functional domain of the Ens-1 promoter and that
sites S2 and S3 were necessary for the interaction with
DNA.
In vivo, mutations in S1 and S3 of the full length pro-
moter contained in the U3 domain from the Ens-1 LTR
[25] totally abrogated promoter activity (Figure 2), con-
firming the importance of these DNA sequences in the
regulation of the whole promoter. Activity was also
strongly inhibited by mutation in site S2 but a very low
and residual activity was still detected confirming the
involvement of additional motifs (Figure 2). Therefore,
the activity of the Ens-1 promoter was based on similar
motifs in embryonic stem cells and in the early embryo-
nic tissues and albeit with different contributions, all S1
to S3 motifs are necessary to sustain the activity of the
whole promoter.
Identification of the transcription factors recruited on the
active binding sites
The Match, Patch and AliBaba2 programs were used to
help in the identification of transcription factors that
may recognize the promoter active sites (see Figure 3A).
The S1 site was recognized as a potential binding site
Figure 1 Four domains cooperate to fully control the p455 promoter activity in cES cells.( A) Sequence of the active domain in the p455
luciferase-reporter construct. Deletions performed between positions -179 and -123 of the p455 promoter relatively to the transcription start site
are indicated in reduced characters, underlined and called a, b, c, d, e, S1, S2, S3, S4. The sequence of the p40 oligonucleotide used as a probe
in EMSA experiments, is bounded above. (B) Luciferase activity from p455 constructs carrying the mutations presented in (A). Mutations
inhibiting the activity are designed S1 to S4 while the others are called a to e. All luciferase activities were normalized by co-transfection of cES
cells with a CMV-renilla luciferase reporter and results are the means of three independent experiments +/- s.d. Statistics are the results of a t
test relatively to the values obtained with the non mutated p455 construct. (C) EMSA were performed with p40 or with the mutated p40
labelled probes (MutS1: GAGCG in place of AGATA; MutS3: AAA in place of GGG) using nuclear extracts from cES cells. (D) EMSA with p40 probe
using nuclear extracts from cES cells or from cES cells induced to differentiate for 4 days with retinoic acid (p40 diff). Mut S2 probe (GCA in
place of ATG) was used with cES extracts. The position of the DNA-protein complexes x, y and z or the probe used alone are indicated with
arrows. For each probe competition, experiments were performed with a 100-fold molar excess of the same unlabelled nucleotide for specific
specific binding (s lanes) or an unrelated nucleotide for nonspecific binding (ns lanes). Results are representative of two others.
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(A/G) [29] while the site S3 overlapped the core motif
GGAA recognized by the Ets 1/2 transcription factors
[30] and by the Churchill transcription factor
(CGGGAA) expressed in the developing nervous system
of chick [31] (Figure 3A). The complete motif for
Nanog binding (TAATGG) [32] was also present in the
Ens-1 promoter and encompasses the S2 motif (Figure
3A). No homology with known transcription factor
binding sites was found for S4. Alternatively, this motif
m a yi n d i r e c t l yi n c r e a s et r a n s c r i p t i o nb yf a v o u r i n gt h e
accessibility of flanking DNA to transcription factors as
described for polydT tracts [33]. To identify which of
these factors may promote the specific activity of the
promoter in ES cells and in the early embryo, their
expression patterns were checked by QPCR analysis
(Figure 3B) and in situ hybridization (Figure 4). As
expected PouV, the chicken homolog of Oct4 [14], and
Nanog were fully repressed in cES cells induced to dif-
ferentiate by retinoic acid, while Sox2 that is not
expressed before the epiblast is fated to become neural
plate in the chicken [34] was strongly induced, even
more than Churchill (Figure 3B). With respect to the
transcription of the six Gata family members, no varia-
tion was observed for Gata1 and Gata6 mRNA; Gata3
mRNA was induced while Gata2, Gata4 and Gata5
were repressed during differentiation. Similarly, Ets2 was
reproducibly induced during the differentiation while
Ets1 was repressed (Figure 3B). Overall these results
show that all the candidates for binding to the S1, S2 or
S3 sites could be detected in cES cells, but the only
ones that were reproducibly repressed during differen-
tiation were Nanog, Ets-1 and members of the Gata
family, Gata2, Gata4 and Gata5. In situ hybridization
experiments in whole embryos (Figure 4) showed that
all these factors, except Gata5, were detected in the epi-
blast at stage XII/XIII from which ES cells were derived.
Ets2 was also detected at this stage. At gastrulation,
Gata and Nanog showed complementary expression pat-
terns within the ectoderm (HH3, Figure 4), and their
combined expression coincided with that of Ens-1. Simi-
larly, Ets1 and Ets2 also showed complementary tran-
scription patterns until stage HH3 (Figure 4).
To confirm the recruitment of these transcription fac-
tors to the promoter, we performed chromatin immuno-
precipitation (ChIP) assays using cES cells expressing
exogenous Ets1, Gata4 or Nanog in fusion with a flag
tag. Untagged factors and a flag-tagged version of the
ubiquitous YY1 transcription factor were used as nega-
tive controls. Results shown in Figure 3C confirmed the
specific recruitment of all the tagged proteins on the
regulatory domain of the Ens-1 promoter when com-
pared with flanking regions. These interactions were sig-
nificantly higher than those obtained with negative
Figure 2 The activity of Ens-1 promoter in vivo involves similar
domains as in cES cells. Epiblast cells of pre-primitive streak
chicken embryos were cotransfected by electroporation with CMV-
DsRed (used to visualize the transfected cells) and U3-GFP vector, in
which U3 contains the whole promoter of Ens-1 (A-C). GFP
expression was compared with U3 constructs presenting the MutS1
(D-F), the MutS2 (G-I), or the MutS3 (J-L) mutations (see Figure 1
legend). As negative controls, mutations on non-functional sites
were performed upstream of site S1 (Mut Ctr1: deletion of site b,
Figure 1A) (M-O) or at position -129 (Mut Ctr2: deletion of the
GTGTG motif) (P-R). The same results were obtained in three
independent experiments.
Mey et al. Retrovirology 2012, 9:21
http://www.retrovirology.com/content/9/1/21
Page 4 of 17controls. Altogether these data indicate that Nanog,
Gata4, and Ets1 expressed in ES cells and repressed
upon differentiation are recruited to the Ens-1 promoter
in pluripotent cells and are good candidates to support
its activity.
Combinations with Ets are required for Gata or Nanog to
support the full Ens-1 promoter activity
The respective roles of Ets and Gata factors in the con-
trol of the Ens-1 promoter were evaluated in differen-
tiated cells which are devoid of Nanog (see Figure 3B)
and in which the promoter activity is repressed [25,27].
Indeed, ES cells induced to differentiate with retinoic
acid lost about 90% of Ens-1 promoter activity, which
was not restored by the ectopic expression of any of the
factors alone (Figure 5A). However combinations of Ets-
1 or -2 with Gata4 induced promoter activity. The tran-
scription factor Churchill, used instead of Ets due to its
potential interaction with the same DNA motif, failed to
synergize with the Gata factors (Figure 5A). Thus the
combination of Ets and Gata4 is necessary and sufficient
to support the Ens-1 promoter activity in differentiated
cells. Some redundancy was observed between the mem-
bers of the same family independently of their regulation
during differentiation (Additional file 2: Figure S2). The
endogenous expression of the Ets and Gata family mem-
bers in differentiated cells may explain the activation of
the Ens-1 promoter by Gata4, Ets1 and Ets2 transfected
separately. However, the best results were obtained with
Gata/Ets combinations, particularly involving either Ets1
Figure 3 Nanog, Ets1 and Gata4 interact with the functional domain of the EnsLTR promoter in cES cells. (A) Binding sites for Gata,
Nanog, Ets and Churchill transcription factors in the functional domain of the Ens-1 LTR are represented in bold and upper characters. The
mutations used in Figure 1 are indicated by underline and italic characters. (B) Real time PCR analysis performed on cDNA from cES induced to
differentiate 48 h with retinoic acid. Expression levels of the indicated transcripts are represented as percentages of the levels obtained in
undifferentiated cES. The numbers that are underlined identify the member of the Gata or of the Ets transcription factors family indicated below.
Means are from three experiments +/- s.d. For Gata3 s.d. is +/- 1097. T test is relative to the values obtained in undifferentiated cells: *p < 0.05,
**p > 0.05. (C) Chromatin-immunoprecipitation of the Ens-1 LTR promoter with anti-flag antibodies in cES transfected with expression vectors
encoding for Nanog, Gata4 or Ets1 proteins in fusion with a flag tag. cES transfected with untagged transcription factors were used as negative
controls. Results obtained with the irrelevant transcription factor YY1 in fusion with a flag tag are also represented. Results represent the fold
enrichment compared to cells transfected with empty vector. The non-specific binding of the tagged transcription factors on upstream and on
downstream regions is represented as well as the non specific interaction of the untagged transcription factors with the binding domain. Means
of at least two experiments +/- s.d. are shown. T test is relative to the values obtained with the tagged YY1 transcription factor, *p < 0.05, **p >
0.05.
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c e l l s( s e eF i g u r e3 B ) .B o t hE t s 1a n dG a t a 4w e r ea l s o
tested for their complementarity with Nanog (Figure
5B). Nanog alone strongly induced promoter activity in
differentiated cells when compared with Gata4 or Ets1.
Nanog combined with Ets1 reached levels of promoter
activity that exceeded even those obtained in undifferen-
tiated cES cells. In contrast no synergy was observed
with Gata4 suggesting that Ets1 was independently
required for both Gata4 and Nanog activities (Figure
5B). When Ets1 was mixed with both Gata4 and Nanog
(Figure 5C), the activity of the promoter was induced at
higher levels than those observed with Nanog/Ets1 but
with a strong variability between experiments as also
observed with Gata4/Ets1 (Figure 5A). Interestingly, in
the absence of Ets1, the addition of Gata4 to Nanog was
not a source of variability in the transcriptional activa-
tion of p455. In contrast, the addition of the CP2 tran-
scription factor enhanced ther e s p o n s et oN a n o g / E t s 1
without increasing the variability, but was neutral when
the promoter was placed under the control of Gata4/
Ets1 (Figure 5C). These data confirmed that CP2 is an
enhancer of Ens-1 promoter activity in ES cells [27]. To
better characterize the additive effect of transcription
factors, we compared the influence of equal quantities
or a 4-fold excess of one of the two co-transfected fac-
tors. In both Gata4/Ets1 and Nanog/Ets1 combinations,
the results were mainly influenced by a decrease in the
Ets1 level (Figure 5D) but with different outcomes. Lim-
iting Ets1 impaired the activity of the Gata4/Ets1 dimer.
This was not the case with Nanog as this combination
still restored promoter activity but with a higher varia-
bility between experiments. Altogether these results
indicate that both Gata4 and Nanog are involved in pro-
moter activity in ES cells and that both cooperate with
Ets1 in an independent manner.
To test whether the active motifs in the Ens-1 pro-
moter that have been characterized in ES cells were
also used in differentiated cells, the combinations that
fully restored the promoter activity were tested on
p455 and on its mutated versions. As expected, the
activation mediated by Gata4/Ets1 or by Nanog/Ets1
was fully impaired by mutations affecting either S1 +
S3 or S2 + S3, respectively, leading to significantly
lower luciferase activities than those obtained in undif-
ferentiated cells with the wild type promoter. None of
the single mutations abrogated the activity obtained
with combinations of the transcription factors to the
same extent. Indeed, with any of the transcription fac-
tors combinations tested, luciferase activities of p455
with single mutations were either not significantly dif-
ferent or higher than those observed in
Figure 4 Expression patterns of E n s 1 ,C P 2 ,E t s 1 ,E t s 2 ,G a t a 2 ,
Gata4, Gata5 and Nanog during early chicken embryo
development detected by in situ hybridization.D o r s a lv i e wo f
preprimitive streak embryos (Stage EG XII/XIII), primitive streak
embryos (stage HH3) and early neurulas (stages HH6-8) are
shown. Embryos are oriented with rostral side toward the top of
t h ep a g ea n dt h ed o r s a ls i d eu p .p s :p r i m i t i v es t r e a k ,n t :
notochord.
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Page 6 of 17Figure 5 Ets factors synergize with Nanog and are indispensable for Gata4 to restore the activity of the p455 promoter in
differentiated cells. (A, B, C, E, F) cES cells induced to differentiate 48 h with retinoic acid (Diff) were transfected with the p455-Luc vector
and with pCi-neo vectors expressing the indicated transcription factors tested in combinations or alone. Equal quantities of each vector were
transfected. (D) Co-transfections were performed as in (A) but with unequal quantities of each vector. The proportion of each is indicated as
parts of five in the figure in the order indicated on the abscissa. (E) Combinations of transcription factors restoring the promoter activity in
differentiated cells were tested on p455-Luc mutated on one or two of the activation sites. (F) Effect of mutations on the activity mediated by
each transcription factors transfected alone in differentated cells. All luciferase activities were measured 24 h after transfection and are
represented as percentages of the value obtained with p455-Luc in cES cells co-transfected with empty vectors (Not Diff.). Results are the means
of at least three independent experiments +/- s.d. In all the figures, t test values are relative to the results obtained in undifferentiated cES cells
with p455-Luc: *p < 0.05, **p > 0.05. For (E) only, t test values relatively to the p455-Luc activity in differentiated cells transfected with a given
combination of transcription factors have also been calculated and are indicated in the text.
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for a given combination of transcription factors, strong
differences in the contribution of each binding site
were revealed when compared to the activity on p455
in differentiated cells (Figure 5E).
As expected, the mutation in S3 (in an Ets binding
site) significantly inhibited the activity mediated by
Gata4/Ets1 or by Nanog/Ets1 on the wild type promoter
(p < 0.05) while the S1 mutation (in a Gata binding site)
only inhibited (p < 0.05) the activity of the Gata4/Ets1
combination (Figure 5E). In contrast, the S2 mutated
version (in a Nanog binding site) did not show signifi-
cant inhibition of the activity (p >0 . 0 5 )a f t e re c t o p i c
expression of Nanog/Ets1 (Figure 5E) suggesting an
indirect effect of Nanog in this combination of exogen-
ous factors. To clarify this result, we evaluated the con-
sequences of the mutations on promoter activity when
expressing only Nanog.
Results shown in Figure 5F indicate that any of the
single or double mutations significantly impaired the
reactivation of the promoter mediated by Nanog, con-
firming the indirect effect and the requirement for intact
S1, S2 and S3 binding sites. Results were different when
expressing the other transcription factors. Although
Gata4 alone failed to reactivate the p455 construct (Fig-
ure 5A and 5F), it reactivated the S2 mutant version to
levels comparable to those obtained with the intact pro-
moter in undifferentiated cells (Figure 5F). This was not
the case with Nanog alone that restored the promoter
activity on wild type p455 only. This indicates that the
indirect effect of Nanog on the promoter activity
required its interaction with the S2 site, probably releas-
ing another DNA binding protein acting as a repressor.
EMSA experiments in human HEK293 cells confirmed
the direct interaction of the transfected chicken protein
Gata4 with S1 site in non-ES cells (Additional file 3: Fig-
ure S3).
In contrast to Gata4, Ets1 was not able to increase the
activity of a S2 mutant version of the promoter, indicat-
ing that the activity mediated by the combination of
Nanog and Ets1 could not be only due to an indirect
effect. The 2.5 (Figure 5B) to 4 (Figure 5E) fold increase
in promoter activity in differentiated versus undifferen-
tiated cells further illustrates the synergy between
Nanog and Ets1.
Altogether these results reveal a functional interplay
between Gata4, Nanog and Ets1 that requires intact S1,
S2 and S3 binding sites, respectively. They also show
the major role played by Ets1 to promote the activity
mediated by Gata4 and by Nanog and also that Nanog
partly acts in an indirect manner, probably by competi-
tion with another DNA binding protein acting as activity
repressor on the S2 site.
Gata4 induces the ectopic expression of Ens-1 in the
developing embryo and is associated with the expression
of Ens-1 in extraembryonic tissues
Nanog and Gata6/Gata4 exert opposite influences on
mammalian pluripotent cells toward the epiblast and the
extraembryonic endoderm respectively [35]. In the chick
embryo the hypoblast is equivalent to the mouse ante-
rior visceral endoderm that derives from the extraem-
bryonic endoderm [36]. The hypoblast expressed Gata4
and Ets2, but not Nanog (Figure. 6A). In agreement
with our results in differentiated cells, in situ hybridiza-
tions in whole embryos revealed the expression of Ens-1
in the hypoblast in addition to the embryonic epiblast
(Figure 6B). Altogether these results are compatible with
ar o l ef o rG a t a 4i nt h em a i n t e n a n c eo ft h eEns-1 LTR
activity in extraembryonic tissues.
To confirm that Gata and Ets factors can support the
activity of the Ens-1 promoter in vivo, Gata4 and Ets1
were overexpessed by electroporation in stage HH3
chick embryos. Interestingly, Gata4 electroporation, but
not Ets1, was sufficient to induce Ens-1 ectopic expres-
sion (Figure 6C). Since Gata4 could not induce Ens-1
promoter activity when used alone in differentiated
c e l l s ,t h e s er e s u l t sm a yb ed u et ot h ee n d o g e n o u s
expression of Ets1 and Ets2 at the electroporation site
(see Figure 4) that can cooperate with Gata4. In con-
trast, Gata factors were not expressed at the electro-
poration site but rather overlapped with Ens-1
expression (see Figure 4), discarding the possibility of
testing the activity of Ets1 ectopically. These results con-
firmed that Gata4 is an activator of the Ens-1 LTR in
vivo acting independently from Nanog. The electropora-
tion of CP2 poorly induced the ectopic expression of
Ens-1 confirming that its enhancer activity mainly
depends of the control exerted by Nanog that was
repressed at that stage (see Figure 4).
Surprisingly, overexpression of Gata/Ets failed to reac-
tivate the expression of Ens-1 in ES cells induced to dif-
ferentiate in vitro with retinoic acid. To assess whether
epigenetic regulations were responsible for this lack of
response, differentiated cells were treated with drugs
that change the chromatin status such as histone deace-
tylase inhibitors (valproic acid and trichostatin A) or a
DNA methyl transferase inhibitor (5-aza-cytidine).
These treatments were sufficient to fully reactivate and
even reach higher levels of Ens-1 transcripts when com-
pared to the expression in ES cells (Figure 7A). These
drugs did not restore the expression of PouV and Nanog
excluding that our results were an indirect consequence
of cell reprogramming. Histone deacetylase inhibitors
did not restore the expression of Gata4, Ets1,o ra n yo f
the Gata factors repressed during differentiation (Figure
7B) indicating that the transcription factors present in
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Page 8 of 17Figure 6 Gata4 induces the expression of Ens-1 in vivo. (A) Nanog, Gata4 and Ets2 transcripts detected by in situ hybridization in stage XIII
(EG) chick blastula. Sections highlight specific expression either in the epiblast or in the hypoblast (black arrow). (B) In situ hybridization in chick
stage XIII (EG) blastula A and in stage 5 (H&H) gastrula B. Sections show Ens-1 expression both in the epiblast (black arrow on a, enlargement on
a’) and in the hypoblast (red arrow in a, enlargement on a’) at blastula stages, and later, at gastrulation, at the border of neural and non neural
ectoderm (black arrow on b’) and in the extraembryonic mesoderm (red arrow on b”, enlargement below). Dotted lines indicate sections’ level.
(C) Epiblasts of preprimitive streak chicken embryos were electroporated for the ectopic expression of GFP alone (A-C) or conjointly with the
transcription factors Gata4 (D-F), Ets1 (G-I) and CP2 (J-L). Ens-1 transcripts were detected ten hours later by in situ hybridization. Results obtained
in 10 out of 19 electroporated embryos with Gata4 (F), in 4 out of 17 with CP2 (L), in 13 out of 13 with Ets1 (I) and in 12 out of 12 (C) with
GFP alone.
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promoter.
These results are in agreement with the existence of
an additional level of regulation that involves epigenetic
silencing, thereby restricting the accessibility of Ens-1
LTR for the binding of transcription factors. This is
likely to occur at developmental stages where Ens-1 is
no longer necessary and is in fact not expressed.
Distribution of the active copies of the Ens-1 promoter in
the chicken genome
The characterization of Ens-1 LTR allowed us to per-
form a new analysis of their distribution on the latest
version of the chicken genome considering only copies
that contain the intact S1, S2, S3 and S4 sites required
for full promoter activity. A total of 227 potentially
active solo-LTR were revealed. Among them, 44 were
l o c a t e da tl e s st h a n2 0k bf r o mg e n e so ri n s i d eg e n e s
(list of 71 genes available upon request), and the rest
were classified as intergenic. It is worth noting here that
an intact TATA box-like sequence (GATAAAA) [27]
was found in 200 out of the 227 (88%) potentially active
solo-LTR and in 40 out of the 44 mentioned (91%) that
are located close to genes. Therefore most of the LTR
with four intact activation domains may support direct
t r a n s c r i p t i o n .M o s to ft h e m( 2 2 5o u to f2 2 7 ,9 9 % )a l s o
have an intact CP2 binding domain (CNRG-N6-CNRG)
shown in a previous paper to support the enhancer
activity of the Ens-1 promoter [27]. This observation
also supports a role for the active LTR in the transcrip-
tional regulation of more distant sequences. The differ-
ent insertions located on the main chromosomes
(1,2,3,4,5 and z) were represented for active and inactive
copies (solo-LTR with at least one mutation in the
motifs S1 to S4) (Figure 8A). Both were located in the
same clusters except for those in the regions surround-
ing the centromeres where we found the inactive but
not the active solo-LTR. This was particularly true for
c h r o m o s o m e s1 ,2 ,3a n d5 .T h e s er e s u l t ss u g g e s ta
non-random distribution of the active and inactive solo-
LTR regarding heterochromatin enriched regions. Inter-
estingly, on chromosome 1, the pluripotency gene
Nanog was located near the centromere and at distance
from active solo LTR. No insertion was found on chro-
mosome 17, which contains the PouV gene that sustains
cES pluripotency [14]. This suggests that pluripotency
supporting genes are preserved from the influence of
Ens-1 LTR, in agreement with a putative role for the
Ens-1 LTR in the control of host genes exerted either in
cis or in trans. To address whether the nearby genes
belong to a particular functional category, gene ontology
annotations of the genes were retrieved from the
Ensembl database using the Biomart tool [37]. The most
represented categories were genes whose products are
associated with the membrane (about 25%) and the
intermediate filaments components (approx. 12%) as
previously observed with other adopted repetitive ele-
ments [38]. LTR with four intact motifs may support
transcription in all the cells of the epiblast and later
maintain expression in the hypoblast (Figure 8B situa-
tion 1/) as observed for Ens-1 although at different
levels (see Figure 6B panel A), perhaps reflecting differ-
ences in transcription factor concentrations. This het-
erogeneity in the epiblast may account for the
emergence of cells forming the extraembryonic endo-
derm or may reflect the association with a maintained
or a delayed function. Interestingly, some nearby genes
of solo-LTR have already been involved in embryonic or
extraembryonic development such as Klf-6 [39],
teneurin-4 fragment [40] or the conserved microRNA
miR-7b involved in the inhibition of Fos [41] that is
required for extraembryonic endoderm epithelial organi-
zation [42]. Alternatively, LTR copies presenting only
Nanog (Figure 8B situation 2/) or Gata/Ets (Figure 8B
situation 3/) binding motifs would show a more
restricted transcriptional pattern in the epiblast. These
situations are compatible with the priming of
Figure 7 Epigenetic regulations silence the Ens-1 LTR in
differentiated cells. cES induced to differentiate 48 h with retinoic
acid (Diff) were further treated with TSA (Trichostatin A, 10 nM), VPA
(Valproic acid, 100 μM) or 5aza (5-aza-cytidine, 100 μM) in
differentiation medium without retinoic acid for 12 h. (A) Expression
levels of Ens-1, PouV and Nanog transcripts measured by real time
PCR. (B) Expression levels of the Gata and Ets1 transcripts that are
repressed during differentiation. Results from three experiments +/-
s.d. are represented as percentages of the value obtained in
undifferentiated cells (Not Diff). T test: *p < 0.05, **p > 0.05 relative
to the values obtained in untreated differentiated cells.
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subsequent role as cells exit pluripotency as summarised
in Figure 8B presenting three potential functional situa-
tions. Importantly, they are all consistent with a role of
Ens-1 LTR in the first developmental decisions through
the production of differentially regulated transcripts in
pluripotent cells.
Discussion
This study addresses the question of whether the activity
of an ERV LTR at very early developmental stages might
be a source of targeted variability in the regulatory path-
ways operating in pluripotent cells. We show that the
balance between the two opposite regulatory pathways
controlling the decision between embryonic and extra-
embryonic tissues is co-opted in the regulation of the
Ens-1 LTR promoter and correlates with its pattern of
transcriptional activity.
We show that in ES cells, the Ens-1 LTR is controlled
by the pluripotency specific transcription factor Nanog
as described for other ERV that escape silencing [7].
However, this LTR is also activated by a combination of
Gata and Ets transcription factors, two families that are
not restricted to pluripotent cells, but whose members
were found here to be expressed in ES cells and in the
epiblast in agreement with a previous report [43]. At
early developmental stages, the expression pattern of
Gata and Ets transcription factors is likely to promote
that of the ERV gene Ens-1,e v e ni nt h ea b s e n c eo f
Nanog, such as in the primitive streak. In agreement
with this observation, electroporation of Gata4 induced
ectopic expression of Ens-1 in embryonic tissues that
expressed Ets1 but not Nanog. In mammals, Gata4 over-
expression is sufficient to transform ES cells into the
extraembryonic endoderm lineage [20], and in agree-
ment with this, we found expression of Gata4 in the
Figure 8 Representation of the active copies of the Ens-1 LTR on the main chicken chromosomes and potential consequences. (A)
Density along the chromosomes 1 to 5 and z, of active solo-LTR (in blue) and inactive solo-LTR (in red) based on the sequence of the four
activation motifs. The blue arrows indicate individual active solo-LTR inserted near genes. Distance in Megabases is indicated on the left scale.
The black arrows indicate the position of each centromere. The purple line on the chromosome 1 indicates the position of the Nanog gene. (B)
Combinations of intact binding sites that recruit transcription factors and may support LTR activity. The expected expression pattern in the
epiblast and in the hypoblast is indicated for the transcripts induced by each type of LTR. Functional interpretation of each expression pattern is
also mentioned. In situation 2, LTR activity is increased by Ets binding but depends on Nanog.
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that Ens-1 was also expressed in this extraembryonic tis-
sue. In post-streak embryonic tissues, a good correlation
was also observed between Gata4 and Ens-1 expression
patterns until the formation of the neural plate (HH6),
but Ets factors were not detected anymore suggesting
the involvement of additional regulators. Indeed, in dif-
ferentiated cells the activation domain attributed to
Nanog was shown to play an indirect role in the activity
mediated by Gata4 in the absence of Ets1. At later
developmental stages Ens-1 is repressed in the whole
embryo [24,25] despite the wider expression of Gata
[44,45] and Ets [46] factors. In accordance with the
silencing mechanisms reported for other ERV [4,8], epi-
genetic regulations are likely to restrict the promoter
accessibility in irrelevant tissues as observed here in dif-
ferentiated cells where the expression of Ens-1 was
strongly induced by treatment with epigenetic modifying
drugs but not by the overexpression of Gata/Ets. Our
results thus reveal that the Gata/Ets combination plays a
role at developmental stages that correlates with the
emergence of the hypoblast while distinct mechanisms
are likely to occur in the neural plate [24,47] and later.
Several lines of evidence indicate that both Nanog and
Ets/Gata regulations are active in ES cells. First, all were
expressed in ES cells; secondly, we found that Nanog,
Gata4 and Ets1 were recruited on the Ens-1 promoter
active domain in ES cells; thirdly, the suppression of the
Nanog binding site only partially suppressed the promo-
ter activity in ES cells and reciprocally with mutations
in the Gata or in the Ets binding sites; fourthly, the
activity mediated by Nanog is increased by Ets-1. This
dual regulation is in agreement with the recent demon-
stration in the mouse that Nanog is required for the
extraembryonic endoderm formation [48] that relies on
the heterogeneity of ES cells populations. Accordingly
distinct levels of the pluripotency marker Nanog are
found among individual ES cells, Nanog-low cells
expressing higher levels of extraembryonic endoderm
markers [49] and being more prone to differentiate [50].
Similarly the epiblast that concentrates pluripotent cells,
also contains cellular sub-populations expressing extra-
embryonic endoderm markers in different species
[51,52]. These cells are likely precursors of the extraem-
bryonic endoderm. Heterogeneity in the expression
levels of Nanog, Ets and Gata factors was also observed
here in stage XII/XIII chick epiblast where the periphery
of the embryo that concentrates Gata factors expressed
lower levels of Nanog transcripts. Despite this heteroge-
neity in the distribution of its regulating transcription
factors, the expression level of Ens-1 was maintained in
the whole epiblast probably reflecting the ability of both
regulation pathways to support the Ens-1 LTR activity
in cells with distinct fates. In embryonic tissues, Ens-1
regulates the timing of Sox2 activation and thus the
emergence of the definitive neural plate [26]. The pre-
sent data support an earlier role of Ens-1 or co-regu-
lated sequences in the process that drives the formation
of the hypoblast from pluripotent cells. Accordingly,
Ens-1 expression was found to be maintained in the
hypoblast.
Experiments performed in differentiated cells revealed
that Nanog as well as the Gata4/Ets1 combination can
restore the promoter activity normally observed in ES
cells. However, additional regulations are likely to favor
one or the other regulation pathway as illustrated by the
transcription factor CP2 that is an enhancer of the Ens-
1 promoter activity in ES cells [27], but was shown here
to solely promote the activation mediated by Nanog.
This balance between opposite active binding sites
provided by the Ens-1 LTR is thus coherent with the
requirements supporting the emergence of the extraem-
bryonic endoderm from pluripotent tissues and may
contribute to this progress. Active copies of the Ens-1
LTR may support in pluripotent cells the specific prim-
ing of genes involved later in the extraembryonic endo-
derm or in the neural plate formation. This is illustrated
with Ens-1 that is expressed in cES cells but involved
later during the neural plate formation [26]. Alterna-
tively the epigenetic silencing of the Ens-1 LTR during
differentiation may serve to repress irrelevant genes
[53,54] according to the heterochromatin formation dur-
ing ES cells differentiation [55].
Genome-wide studies combined with transcriptome
analysis have concluded that LTR promoters may have
an impact on tissue specific transcription [56,57]. We
show here that only 26% (227 on 874 [22]) of the Ens-1
LTR copies in the chicken genome contain an intact
activation domain that supports transcriptional activity
in the early embryo. Most of them are far from genes,
and one third is localized in or at less than 20 kb of
host genes, a distance that is compatible with a promo-
ter activity and may direct gene functions in specific tis-
sues. They may also act as enhancers inducing the
transcription in both orientations [25] of non-coding
RNA from intergenic loci [58]. Such sequences are
known to be important players during development [59]
and may be involved in the guidance of chromatin-mod-
ifying complexes on specific targets [60] as required
during ES cells differentiation [61-63]. The presence of
active LTR near genes already involved in embryonic or
in extraembryonic development as listed here is in
favour of relevant species-specific adaptations.
Conclusion
Our results demonstrate that the Ens-1 LTR support
gene expression in pluripotent and in extraembryonic
tissues thus providing conditions for cell priming
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bryonic endoderm cells from ES cells. In addition to
Ens-1, transcriptome analysis based on active LTR distri-
bution along the genome will serve as a basis to explore
their contribution in the regulation of other genes and
their role in defining ES cells subpopulations with dis-
tinct cell fates.
Methods
Cell culture and DNA transfection
The culturing of cES cells and their differentiation by
retinoic acid 10
-6 M have been previously described
[27]. cES cells or cES cells induced to differentiate 48
hours by retinoic acid were transfected using Lipofecta-
mine 2000 reagent (Invitrogen) with p455-Firefly Luci-
ferase reporter construct containing the Ens-1 minimal
promoter, the Renilla Luciferase reporter construct,
pRL-CMV, to normalize for transfection efficiency and
expression vectors for transcription factors used alone
or in combinations. Except when mentioned, an equal
quantity of each expression vector was used and total
DNA quantity between conditions was maintained con-
stant using empty vector. Twenty-four hours after trans-
fection the Firefly and Renilla Luciferase luminescences
were successively measured using Dual Luciferase Assay
(Promega) as described by the manufacturer. Firefly
reporter gene values were normalized to the activity of
the Renilla luciferase. Chromatin modifying drugs Tri-
chostatin A (TSA), Valproic acid (VPA) and 5-azacyti-
dine (5-aza) were from Sigma.
HEK (Human Embryonic Kidney) 293 cells were from
ATCC (CRL-1573) and cultivated in DMEM (Gibco)
supplemented with 10% fetal bovine serum (Perbio) as
recommended by the supplier.
DNA binding assays
The preparation of DNA binding assays and nuclear
extracts was performed as previously described [27]
using double-stranded DNA probes labelled with
32P
-
ATP (Amersham). For competition experiments, a 100-
fold molar excess of unlabelled double-stranded nucleo-
tide, synthesized by Sigma, was incubated for 10 min
with nuclear extract prior to the addition of the labeled
double-stranded probe. For supershift experiments in
HEK293 cells anti-Flag M2 antibody was from Sigma.
Whole IgG purified from mice were from Zymed.
DNA constructs and site directed mutagenesis
The luciferase reporter construct p455-Luc was done
using the pGL2 basic vector (Promega) as previously
described and includes the LTR sequence from -455 to
+83 of the transcription start site [27]. Targeted muta-
genesis by deletions was performed using the Quick
Change Mutagenesis Kit (Stratagene) following the
manufacturer’s instructions. The U3-GFP construct
expresses a GFP reporter gene placed under the control
of to the sequence from -738 to +83 of the transcription
start site described before [25]. This largest construct
contains the 738 bp of the promoter defined previously
[27] which is present in the U3 region of the LTR of
Ens genes [25]. Both p455-Luc and U3-GFP contain 83
bp from the R region 5’ end starting downstream the
transcription start site [25].
Site directed mutations were performed by replace-
ments or by deletions of bases as indicated in the figure
legends. Large deletions in the constructs p455 del 128-
87, del 128-57 del 179-128, del 179-87, del 179-57 and
del 237-31 were obtained by ligation of two PCR ampli-
fied fragments surrounding the deletion. The transcrip-
tion factors were cloned in a pCi-Neo expression vector
(Promega) modified to introduce a flag tag at the N-
terminal part of the protein. Ets-2 (Genbank:X07202),
Gata3 (Genbank:XM_417294), Gata4 (Genbank:
XM_420041) and Gata5 (Genbank:NM_205421) were
amplified from chicken ES cells cDNA. Chicken Ets-1
(p54, Genbank:X13026) was given by Dr B. Wasylyk
[64], Churchill (Genbank:AF238863) was a gift from Dr
C. Stern [31]. For over-expression experiments in the
embryo, transcription factor coding sequences were
placed under the control of the CAG promoter (a
chicken b-actin promoter combined with CMV enhan-
cer) to ensure strong expression [65]. The predictions
for transcription factor binding sites were carried out
using the indicated programs available online (http://
www.gene-regulation.com/pub/programs.html).
Real time PCR
RNA was extracted using an RNeasy kit with on-column
DNase digestion (Qiagen). Reverse transcription was car-
ried out with 1 μg of RNA and SuperScript III (Invitro-
gen). Real-Time PCR was performed using the MXP-300P
PCR-system (Stratagene), Mix-Quantitect SYBR Green
(Qiagen) as reagent under the following cycling condi-
tions: 40 cycles at 95°C for 30 seconds, at 55°C for 1 min-
ute and 72°C for 30 seconds. Samples were run in
duplicate and gene expression levels were calculated using
Delta Ct (http://www.gene-quantification.info/) normal-
ized with the chicken 40S ribosomal protein S17 as house-
keeping gene. The primers used are listed in Table 1.
Chromatin immunoprecipitation
ES cells were transfected using Lipofectamine 2000
(Invitrogen) with pCi vectors encoding for the indicated
transcription factor in fusion with a Flag tag. The fol-
lowing day, cells were fixed with formaldehyde, collected
and lysed in 50 mM Tris-HCl (pH 8.1), 10 mM EDTA,
0.5 mM EGTA, 1% (w/v) SDS, and proteases inhibitor
for 5 minutes on ice. The cells were then sonicated to
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pairs. Sonicated chromatin was diluted 1/10 with the
following buffer: 20 mM Tris-HCl (pH 8.1), 1% (v/v)
Triton X-100, 150 mM NaCl, 1 mM EDTA and pro-
teases inhibitors. Immunoprecipitation was carried out
overnight at 4°C with 50 ml of agarose beads coated
with anti-Flag M2 antibody (Sigma). Beads were washed
extensively, and bound material was eluted by two incu-
bation rounds of 15 minutes in 1% (w/v) SDS and 0.1
M NaHCO3 at room temperature. Cross-linking was
reversed by incubation 4 h at 65°C in 200 mM NaCl
and 100 mg/ml proteinase K. The DNA was purified
using Mini-Elute columns (Qiagen). Aliquots were used
for quantitative real-time PCR as described above. The
oligonuclotides used were designed either inside the
p455 region (GAGGAACAAGTCCAGGCAAG;
GATGGCCATTTTCCTTGAGA), or 1000 bp upstream
(CCCACGGTACACAATGAACA; GCTAGG-
GAGCCCTTTAACCA), or 1000 bp downstream
(TGGTGTGGTGTTTGCAGTTT; CCCTTTGTTGAG-
GAAAGCAC) from the Ens-1 copy on chromosome 5.
The region bounded by the primers designed inside the
p455 sequence is located between positions -278 and
-93 from the transcription start site.
Embryos
Fertilised chicken eggs were purchased from Granja
Santa Isabel, Cordoba, Spain. Eggs were incubated,
opened and staged according to Eyal-Giladi and Kochav
[66] for the pre-primitive streak stages and Hamburger
and Hamilton [67] for subsequent stages. They were dis-
sected and fixed overnight in 4% paraformaldehyde in
phosphate buffered saline (PBS) at 4°C.
Chicken embryos electroporation
Stage 2-4 [67] chick embryos were explanted, washed in
PBS, and placed upside down over an electroporation
chamber (NEPAGEN) containing a platinum electrode
connected to the negative pole. After visualizing the
embryo, a solution containing expression plasmids (2
mg/ml in PBS with 0.1% Fastgreen and 6% sucrose) was
injected between the vitelline membrane and the epi-
blast. An anodal electrode was placed over the hypoblast
to cover the injected area and contact was made with
PBS. A train of electric pulses (5 pulses, 4 Volts, 50 ms,
0.5 Hz) were applied using an Intracept TSS10 pulse sti-
mulator (Intracell). The embryos were then placed in
culture as described [68] and allowed to develop until
they reach the required stage. Embryos were then
photographed with a Leica MZFLIII dissecting micro-
scope to record GFP or DsRed expression and fixed
overnight in 4% paraformaldehyde (PFA) in PBS at 4°C
for subsequent processing.
Whole mount in situ hybridization
Whole-mount in situ hybridization was carried out in
chick embryos at various stages of development as pre-
viously described [69]. Digoxigenin-labelled probes for
E N S 1[ 2 5 ] ,C P 2[ 2 7 ] ,E t s 1 ,E t s 2 ,G a t a 2 ,G a t a 4 ,G a t a 5
and Nanog with digoxigenin-UTP (Roche) were synthe-
sized. After hybridization, embryos were fixed in 4%
paraformaldehyde in PBS, washed in PBS, and photo-
graphed in whole-mount under a Leica M10 dissecting
scope. Subsequently, some embryos were embedded in
gelatine and sectioned in a vibratome at 40 μm. These
slices were photographed using an Olympus DP70 digi-
tal camera mounted on a Leica DMR microscope with
Nomarski optics.
Detection and localization of solo-LTR in the chicken
genome
Using the sequence of the Ens-1 LTR as a reference, the
occurrence of solo-LTR were searched in the latest ver-
sion of the chicken genome (release galGal3) that was
Table 1 Oligonucleotides used for gene expression analysis
Gene Sense (5’-3’) Anti-sense (5’-3’)
RS 17* ACACCCGTCTGGGCA ACGACT CCCGCTGGATGCGCTTCATCA
Gata1 CACTGCACTCCGACATCCA GTACCAAGATCCCACAGTCCTT
Gata5 CTTCCATTACGAACTCAGACAGCAC GGACACCGACACAATGCCTTG
Gata6 GAATTCAGACGAGGAAACGAAAACC ACGTAGATGTTGGAGTCATAGGAAC
Ets-1 CCAGCTTCATCACAGAGTCCTACC AGGGATAGTCGTTCTCGTACTTGAG
Ets-2 CAGAGGAATGCTCAAGCGGC GCACTTCCTGGAGCGTTTGA
Churchill ATCATCACCTACGACCACCTG CAGGGTTACAAACTGCCTTCA
Sox2* GCAGAGAAAAGGGAAAAAGGA TTTCCTAGGGAGGGGTATGAA
Nanog* CAGCAGACCTCTCCTTGACC TTCCTTGTCCCACTCTCACC
PouV* GTTGTCCGGGTCTGGTTCT GTGGAAAGGTGGCATGTAGAC
Ens-1 CACCAGTCAGGACCCAAAGT GGGGATGAAACCTTTTTGGT
Primers for gallus Gata2, Gata3 and Gata4 were purchased from Qiagen
* Primers previously described [64]
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load.cse.ucsc.edu/downloads.html) using blastn [70]. We
classified each solo-LTR as active or inactive according
to the presence or absence of the motifs identified as
being essential to its activity by using the program fuzz-
n u cf r o mt h eE M B O S Sp a c k a g e[ 7 1 ] .W et h u so b t a i n e d
227 active solo-LTR and 916 inactive solo-LTR. Using
the Ensembl facilities [72] (http://www.ensembl.org/
index.html), we mapped the distribution of each type of
solo-LTR on the chromosomes. By combining the posi-
tions of the active solo-LTR and those of the genes, we
determined the active solo-LTR inserted close to genes
(at less than 20 kb or inside the genes). Genes ontology
annotations were retrieved from the Ensembl database
using the Biomart tool [37] (http://www.ensembl.org/
index.html).
Additional material
Additional file 1: Figure S1. The -179 to -128 bp residue upstream
of the transcription initiation site is required for the p455 promoter
activity.( A) Schematic representation of the wild-type p455 reporter
construct used in transfection experiments and position of the different
deletion edges of the constructs used in (B). (B) cES cells were
transfected with wild type or with one of the deleted p455 (p455 Del)
luciferase reporters illustrated in (A). All luciferase activities were
normalized by co-transfection with a CMV-renilla luciferase reporter. (C)
The contribution of two putative Gata binding sites to the promoter
activity of p455 was examined. Site directed deletions were performed in
one of the following positions: Gata n°2: TATC -111/-114 or Gata n°3:
TATC +47/+50. The deletion in site S1 described in Figure 1 and
showing inhibition is used as reference. Luciferase activities obtained
with these constructs in cES cells were compared to that obtained with
wild type p455 as indicated in (B). Means are +/- s.d. of at least three
independent experiments. Statistics are from t tests relative to the value
obtained with p455.
Additional file 2: Figure S2. Redundancy between Gata factors to
restore the activity of the p455 promoter in differentiated cells.
Experiments were performed as indicated in Figure 4 with equal
quantities of pCi-neo vectors expressing the indicated transcription
factors transfected in cES cells induced to differentiate 48 h with retonoic
acid (Diff). Results are percentages of the value obtained with p455-Luc
in cES cells transfected with empty vector. All the results are the means
of three independent experiments +/- s.d. T test: *p < 0.05, **p > 0.05,
relative to the values obtained in undifferentiated cells (Not diff.).
Additional file 3: Figure S3. Direct interaction of Gata4 with the site
S1 of the promoter sequence. HEK293 cells were transfected with
expression vectors encoding for the Gata4 protein in fusion with a flag
tag or untagged as control. Nuclear extracts were used for EMSA assays
with the labelled p40 probe or with p40 probes mutated in sites S1, S2
or S3. Supershifts were performed using an anti-Flag antibody or whole
IgG as control; both used at 1 μg per lane. On the right is represented
the result obtained with untransfected HEK293 cells. This lane is from the
same gel but moved from the opposite side. Results are from one
experiment representative of two.
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